Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buying the dip here
This hidden board for Cannabix
ORIGINAL: Cannabix Technologies Creates Contactless Alcohol Breath Detection Technology for Vehicles - Files Provisional Patent
VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the "Company or Cannabix") developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company has developed a cutting-edge Contactless Alcohol Breathalyzer for vehicle cabins. The prototype Contactless Alcohol Breathalyzer ("CAB") was developed by Cannabix after being approached by a Tier 1 global automobile parts manufacturing company seeking to source new technology that could be used in a contactless (no straw, no mouthpiece) method. The Company has entered into a non-disclosure agreement with the Tier 1 global automobile parts manufacturer. The first proof of concept prototype of the CAB has been developed for a vehicle cabin with specialized placement of such technology. Cannabix has used its years of experience in breath testing and breath capture technology for marijuana to rapidly develop a working CAB prototype, with a small enough footprint that could be developed for virtually any make or model vehicle. The Company has not entered into any contractual relationship for its CAB technology. The Company has filed a provisional patent application for its CAB technology.
The first CAB proof of concept prototype would allow for a driver to direct a breath sample towards a small orifice integrated into the cabin of a vehicle - in a completely contactless manner. The CAB is fundamentally different than existing alcohol interlock systems that require users to use a mouthpiece and directly blow into a handheld device that is connected to the vehicle usually with a cable. The Cannabix CAB has been designed for specific placement inside the vehicle cabin, however could be outfitted various locations in the vehicle cabin. The CAB provides a warning, pass or fail result along with a Blood Alcohol Content (BAC) level on the screen for the driver to see. This kind of technology holds potential to be integrated with interlock systems and be used in many settings including automotive, heavy-duty equipment including heavy transport vehicles, watercraft and workplace monitoring.
In the United States, the November 2021 Infrastructure Investment and Jobs Act (IIJA) passed by the House of Representatives called for new cars to come equipped with technology that will detect alcohol in breath. The legislation directs the National Highway Traffic Safety Administration to set new safety standards within three years for impaired driving safety equipment on all new vehicles (1) (2).
Manufacturers such as Volvo have experimented with offering alcohol-detection systems as optional equipment. A public-private partnership called the Driver Alcohol Detection System for Safety (DADSS) project is also testing their own system.
(1) https://www.iihs.org/news/detail/alcohol-detection-systems-could-prevent-more-than-a-fourth-of-u-s-road-fatalities
(2) https://www.madd.org/press-release/auto-technology-that-stops-drunk-driving-now-required-by-law
Readers are cautioned that, although the Company has achieved proof of concept prototype for the CAB, the testing method and device is still in the preapproval stage and accordingly the Company is not currently making any express or implied claims that the technology will proceed to commercial use.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace. Cannabix is working to develop drug-screening devices that will detect THC - the psychoactive component of marijuana that causes impairment using breath samples. Breath testing for THC would allow employers and law enforcement to identify recent marijuana use that better aligns with impairment. Cannabix devices are in the advanced prototype and pre-clinical testing stage.
We seek Safe Harbor.
On behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
The news of expansion for production is nice.... I’m awaiting the news of production or “Sold”....
another test facility in the US going to give an opinion on what we've got.
Crazy azz ride that came back quite a bit with management cashing in.
so has anybody been watching this latley keeps increasing maybe its time has come
We are in the index... so maybe plus 5 states will reflect. A little.
6 mos jump due soon
New listing next week First Responder Technogies to detect concealed weapons
Take a look trans Jan 16
First Responder Technologies Inc
Symbol WPN
Shares Issued 54,929,396
Recent Sedar Documents
View Original Document
First Responder Technologies to trade on CSE Jan. 16
2020-01-10 15:58 PT - New Listing
CSE bulletin 2020-0111
The common shares of First Responder Technologies Inc. have been approved for listing on the Canadian Securities Exchange.
Listing and disclosure documents will be available on the CSE website on the trading date.
First Responder Technologies is a technology development company based in Vancouver, B.C., developing a WiFi-based concealed weapons detection system, focused on protecting the perimeter of soft targets, such as places of worship, theatres, shopping centres and sports venues, where the public is most vulnerable to acts of terrorism and mass shootings.
Issuer: First Responder Technologies
Security type: common shares
Symbol: WPN
Number of securities issued and outstanding: 54,929,396
Number of securities reserved for issuance: 14,593,829
CSE sector: technology
Cusip No.: 33618F 10 1
ISIN: CA33618F 10 1 8
Board lot: 500
Initial public offering price: 35 cents
Agent: PI Financial Corp.
Trading currency: Canadian dollar
Listing date: Jan. 13, 2020
Trading date: Jan. 16, 2020
Other exchanges: not applicable
Fiscal year-end: June 30
Transfer agent: Computershare Investor Services Inc.
The exchange is accepting market-maker applications for WPN.
© 2020 Canjex Publishing Ltd. All rights reserved.
New listing next week First Responder Technogies to detect concealed weapons
Take a look trades Jan 16
https://www.firstrespondertech.com
First Responder Technologies Inc
Symbol WPN
Shares Issued 54,929,396
Recent Sedar Documents
View Original Document
First Responder Technologies to trade on CSE Jan. 16
2020-01-10 15:58 PT - New Listing
CSE bulletin 2020-0111
The common shares of First Responder Technologies Inc. have been approved for listing on the Canadian Securities Exchange.
Listing and disclosure documents will be available on the CSE website on the trading date.
First Responder Technologies is a technology development company based in Vancouver, B.C., developing a WiFi-based concealed weapons detection system, focused on protecting the perimeter of soft targets, such as places of worship, theatres, shopping centres and sports venues, where the public is most vulnerable to acts of terrorism and mass shootings.
Issuer: First Responder Technologies
Security type: common shares
Symbol: WPN
Number of securities issued and outstanding: 54,929,396
Number of securities reserved for issuance: 14,593,829
CSE sector: technology
Cusip No.: 33618F 10 1
ISIN: CA33618F 10 1 8
Board lot: 500
Initial public offering price: 35 cents
Agent: PI Financial Corp.
Trading currency: Canadian dollar
Listing date: Jan. 13, 2020
Trading date: Jan. 16, 2020
Other exchanges: not applicable
Fiscal year-end: June 30
Transfer agent: Computershare Investor Services Inc.
The exchange is accepting market-maker applications for WPN.
© 2020 Canjex Publishing Ltd. All rights reserved.
The latest news is about saliva testing device approval, despite the fact that it has human rights issues and needs a court order. I know other countries are using it because idiots imitate idiots. There's jobs and drivers licenses on the line and politicians are leaning towards the swabalyzer out of desperation to have something for law enforcement. The Cannabix THC breathalyzer doesn't collect dna, only measures recent use, not last weekends weedfest. It is well thought out to be fair and accurate with respect to recent use. I don't know where this herd of sheeples will run to over old news for a device that won't do the job. The Cannabix THC breathalzyer is the closest we have to detecting recent use thc and the probability that a driver or employee may be high. Government will be forced to switch to a legal device when it is ready. glta and dyodd
go to the other cannabix board
https://ih.advfn.com/stock-market/USOTC/cannabix-technologies-inc-BLOZF/stock-price
Been holding 2 years for a reason not expecting it to double but expecting it to go boom
Did not sell...and glad I was right!
JosiePicks
Hope you didn’t sell
You mean 10.00 $$$$$ +++
Will hit $1.00 by January 1st
BLO shareholders stunned by the massive 2 cent drop today. 164 suicide attempts thwarted by SEC crisis hotline..
Turning to financial news.."BLO" was down 1 cent. Goodnight.
BLO...like the best behaved kid in your town. No babysitter required.
Up a penny...even.. .so relaxing..
ontario government set to approve the swab.
https://news.ontario.ca/mto/en/2017/09/proposed-new-measures-for-drug-impaired-driving.html
http://www.cbc.ca/news/canada/toronto/ontario-drug-impaired-driving-laws-1.4294900
Communist more than socialist soon...sad
A minister for the government of ontario held a press conference yesterday stating that they were introducing a zero tolerance for impaired driving for drugs and alcohol. he also said that these new rules would have stiffer penalties for anyone under the influence of any drug. this is obviously a sign that they are going to approve the swab device they tested last year and hope that people pay the fine rather than challenge in court. another wynne money grab. i do not believe the swab will stand up in court but they are going to try since the swab tests for pretty much eveerything including prescription drugs. this is what the government really wants. ontario will be the test case. they also announced fines and or suspensions for refusing to allow police to administer their test. this caveat would not be neccessary for a breathalyzer...only for the invasive swab since they know most, if not, all people would refuse the swab.
https://www.thestar.com/news/queenspark/2017/09/18/ontario-to-toughen-penalties-for-driving-under-the-influence-of-marijuana.html
The angle is good..while everybody is buying pot stocks, we are looking at the spinoff business from pot. One government contract someday then it's off.."If"...
Where on the same page ! Same thing with owcp if it hit gonna be huge
Agreed about the coin flip.. I made a post when I bought it saying "If these guys can pull this off"..the upside would be huge though. "If"...
Worth the risk in my eyes. Time will tell.
Opening the door on both exchange eventually opens door to more investors in this case very low volume on both sides, I look at the stock as a coin flip can go either way
I like that..127 trades..double US ex. I don't really know how this works by having the same company in 2 exchanges in different countries but since this is a canadian company, you would think that watching BLO on the Canadian side would tip you off earlier than the US side? Unless I completely have no understanding of the two country stock deal...
Wtf..up 3 cents..lol..thats like an eruption..hahaha
Wtf..up 3 cents..lol..thats like an eruption..hahaha
What a peaceful stock and board this is...lol. up a penny, down a penny. Even..kind of relaxing in a way compared to my other up and down toilet seat stocks..deep breaths now...again..hahahaha
Started this Board for the IHUB New Releases to post for Cannabix, also BLOZF Board with many good folks keep it real what's happening here, some believe there's gonna be a winner of being 1st but BLOZF gonna just do it right, we have the players here with Yost Huestis Goldberger - Pre-Game starts in Sept and best to just grab a seat now, cause the Super BLO (When Testing Trials Get Started), yeah the Super BLO will gain all here someone wanting their chair
Know you are a cheerleader here shell so like the idea if this could ever be developed. Could be another tasr like investment? Anyway, it might take awhile for this to go but got some today..gl blo
Live Testing with Cannabix Marijuana Breathalyzer Shows Excellent Sensitivity for THC and Related Metabolites
http://thecse.com/sites/default/files/Cannabix_Technologies_Breath_Testing_March_27_2017_Final.pdf
86,306,267 common shares
As of Date April 5, 2017
Rick Yost, PhD, Scientific Advisor
Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida. Dr. Yost’s research has involved over 100 graduate students funded by over $40 million in research grants, and has published over 160 papers and 16 patents. Over $30 billion worth of instruments have been sold based on these patents.
Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016). Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine.
Dr. Bruce Goldberger, PhD, Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida. Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.
Raj Attariwala, MD, PhD, Chief Scientific Officer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL). Dr. Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver. He has pioneered advances in the field of whole body medical imaging through his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr. Attariwala has worked closely with the breath testing technology leaders and has utilized his educational training and background in biomedical engineering to formulate product design and patent applications for Cannabix. Dr. Attariwala also has several other medical device patents under developments in the field of nuclear medicine.
Dr. Jared Boock, PhD, Lead Developer
Dr. Boock has extensive experience in working with high-field asymmetric waveform ion mobility spectrometry (FAIMS)-based methods. He served nine years in the US Air Force working in research, development, testing, and fielding of new devices for explosives and volatile organic compound (VOC) detection.
Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).
The black "?" Are a rocking todaythe number actually dropped off at one point 77110
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
53
|
Created
|
04/06/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads